Clinical Trial Update: Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on KN057 for prophylaxis in patients with Hemophilia A or B with inhibitors; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• KN057

Snippet

Sponsor: Suzhou Alphamab Co., Ltd. | Conditions: Hemophilia A With Inhibitor, Hemophilia B With Inhibitor | Phase 3 | Status: ACTIVE_NOT_RECRUITING